Fusion Pharmaceuticals Header

Imaging Scientist, Theranostics

Boston, MA

Job Description

 

Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes but is not limited to: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. To support execution for these programs, Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radioconjugate manufacturing facility to meet supply demand for our growing pipeline of RCs.

Candidates for the Imaging Scientist, Theranostics role need to work on a hybrid basis out of our Boston, Massachusetts office.

Responsibilities

  • Assist in the development of, and adherence to, imaging trial documents (e.g., Image Review Charter, Imaging Manual, Data Transmittal Forms, and Dosimetry Manuals). 
  • Provide subject matter expertise to internal and external stakeholders in matters of image acquisition, storage, review, and processing. 
  • Maintain an archive of imaging related data for ongoing and completed trials. 
  • Collaborate with clinical operations in the oversight, conduct and management of imaging-related aspects of clinical studies in accordance with the clinical protocol, study manuals and plans, and timelines while ensuring quality in accordance with GCP and ICH guidelines. 
  • Assist with the management of in-house processing of image data and internal dosimetry efforts to support ongoing research and multi-disciplinary department and company initiatives. 
  • Provide support for clinical data review; assist in generation of clinical research reports and presentations including abstracts, posters, and publications. 
  • Provide support to clinical site staff and investigators pertaining to preparation, administration, and waste management of imaging and therapeutic radiopharmaceuticals. 
  • Respond to radiation safety questions and concerns regarding the use of diagnostic and therapeutic radiopharmaceuticals and precautions. 
  • Have a working knowledge and understanding of modern electronic infrastructures relevant to radiological imaging such as DICOM, PACS, IHE models, image processing and advanced visualization. 
  • Willingness to travel when needed (5-10%)

Qualifications

  • The candidate should have a Bachelor of Science degree with a life science focus from an accredited educational institution and NMTCB/ARRT(N) certification in nuclear medicine or equivalent. Additional training in radiation safety (NMTCB(RS)) and/or medical physics with an advanced master's qualifications is preferred but not required.
  • Minimum of at least 5 years of clinical experience.
  • Experience working in clinical trials for 2-5 years is preferred but not required.
  • Demonstrated technical and analytical problem-solving skills.
  • Scientific expertise in SPECT and PET imaging is strongly preferred, including acquisition, reconstruction and uploading of images. 
  • Training in Good Clinical Practices (GCP), Quality Assurance/Compliance (QA/QC) in a clinical trial setting is preferred. 
  • Experience with radioactive materials license amendment process with the NRC and Agreement States. 
  • Familiar with Radiation Safety Officer (RSO) responsibilities. 
  • Ability to clearly articulate and present the role and impact of molecular imaging on decision making within drug discovery and development. 
  • Self-motivation and exceptional verbal and written communication skills. 
  • Ability to multi-task and work effectively in a team or independently on assigned tasks. 
  • Proficiency in business computer skills and experience with medical imaging workstations 
     (i.e., MIM), dosimetry software, and/or PACS preferred.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.

 The annual base pay for this position ranges from $86,684 to $130,026. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.



PDN-a09c860a-211e-4d51-a601-c2babaac8dde
 

Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes but is not limited to: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. To support execution for these programs, Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radioconjugate manufacturing facility to meet supply demand for our growing pipeline of RCs.

Candidates for the Imaging Scientist, Theranostics role need to work on a hybrid basis out of our Boston, Massachusetts office.

Responsibilities

  • Assist in the development of, and adherence to, imaging trial documents (e.g., Image Review Charter, Imaging Manual, Data Transmittal Forms, and Dosimetry Manuals). 
  • Provide subject matter expertise to internal and external stakeholders in matters of image acquisition, storage, review, and processing. 
  • Maintain an archive of imaging related data for ongoing and completed trials. 
  • Collaborate with clinical operations in the oversight, conduct and management of imaging-related aspects of clinical studies in accordance with the clinical protocol, study manuals and plans, and timelines while ensuring quality in accordance with GCP and ICH guidelines. 
  • Assist with the management of in-house processing of image data and internal dosimetry efforts to support ongoing research and multi-disciplinary department and company initiatives. 
  • Provide support for clinical data review; assist in generation of clinical research reports and presentations including abstracts, posters, and publications. 
  • Provide support to clinical site staff and investigators pertaining to preparation, administration, and waste management of imaging and therapeutic radiopharmaceuticals. 
  • Respond to radiation safety questions and concerns regarding the use of diagnostic and therapeutic radiopharmaceuticals and precautions. 
  • Have a working knowledge and understanding of modern electronic infrastructures relevant to radiological imaging such as DICOM, PACS, IHE models, image processing and advanced visualization. 
  • Willingness to travel when needed (5-10%)

Qualifications

  • The candidate should have a Bachelor of Science degree with a life science focus from an accredited educational institution and NMTCB/ARRT(N) certification in nuclear medicine or equivalent. Additional training in radiation safety (NMTCB(RS)) and/or medical physics with an advanced master's qualifications is preferred but not required.
  • Minimum of at least 5 years of clinical experience.
  • Experience working in clinical trials for 2-5 years is preferred but not required.
  • Demonstrated technical and analytical problem-solving skills.
  • Scientific expertise in SPECT and PET imaging is strongly preferred, including acquisition, reconstruction and uploading of images. 
  • Training in Good Clinical Practices (GCP), Quality Assurance/Compliance (QA/QC) in a clinical trial setting is preferred. 
  • Experience with radioactive materials license amendment process with the NRC and Agreement States. 
  • Familiar with Radiation Safety Officer (RSO) responsibilities. 
  • Ability to clearly articulate and present the role and impact of molecular imaging on decision making within drug discovery and development. 
  • Self-motivation and exceptional verbal and written communication skills. 
  • Ability to multi-task and work effectively in a team or independently on assigned tasks. 
  • Proficiency in business computer skills and experience with medical imaging workstations 
     (i.e., MIM), dosimetry software, and/or PACS preferred.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.

 The annual base pay for this position ranges from $86,684 to $130,026. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.



PDN-a09c860a-211e-4d51-a601-c2babaac8dde

About Fusion Pharmaceuticals

At Fusion, we are pushing the boundaries of science to create innovative precision medicines for cancer.

We are a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. We have developed our Targeted Alpha Therapies, or TAT, platform together with our proprietary Fast-Clear™ linker technology to enable us to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the therapies to tumors.

We believe our proprietary Fast-Clear™ linker technology is a safer approach to targeted radiopharmaceuticals. Fast-Clear™ represents a revolutionary step towards developing safe and effective new radiotherapeutics as the standard of care for the treatment of multiple tumor types.

We believe this evolution of radiopharmaceuticals holds great promise to improve the lives of patients with cancer.


Related Jobs

Apply For This Job
Imaging Scientist, Theranostics
Fusion Pharmaceuticals
Boston, MA
Dec 17, 2025
Your Information
First Name *
Last Name *
Email Address *
This email belongs to another account. Please use a diferent email address or Sign In.
Zip Code *
Password *
Confirm Password *
Create your Profile from your Resume
By clicking the Apply button, you agree to the terms of use and privacy policy and consent to receive emails from us about job opportunities, career resources, and other relevant updates. You can unsubscribe at any time.
Supercharge Your Resume with AI

Boost your resume with AI-driven enhancements. The tool analyzes and refines your content, highlighting your strengths and tailoring it for maximum impact. Get personalized suggestions and apply improvements instantly to stand out in the job market.

©2025 International Association of Women.
Powered by TalentAlly.